Symbol Name ID |
Nfkbia
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha MGI:104741 |
Darker colors indicate more annotations |
Human Phenotypes | Increased circulating IgA level |
Increased circulating IgG level |
Polyclonal elevation of IgM |
Decreased circulating antibody level |
Paraproteinemia |
Impaired lymphocyte transformation with phytohemagglutinin |
Lymphadenopathy |
Splenomegaly |
Recurrent infection of the gastrointestinal tract |
Subacute progressive viral hepatitis |
Defective production of NFKB1-dependent cytokines |
Recurrent respiratory infections |
Disease(s) Associated with NFKBIA | ||||||||||||
ectodermal dysplasia and immunodeficiency 2 | ||||||||||||
hepatocellular carcinoma | ||||||||||||
Hodgkin's lymphoma | ||||||||||||
multiple myeloma |
Mouse Phenotypes | increased activation-induced B cell apoptosis |
increased T cell apoptosis |
abnormal granulocyte differentiation |
decreased B cell proliferation |
increased B cell proliferation |
decreased T cell proliferation |
increased T cell proliferation |
thymus atrophy |
decreased thymocyte number |
increased thymocyte number |
abnormal B cell differentiation |
decreased transitional stage T2 B cell number |
increased immature B cell number |
increased pro-B cell number |
decreased double-negative T cell number |
decreased double-positive T cell number |
increased double-positive T cell number |
abnormal myelopoiesis |
abnormal granulocyte morphology |
increased granulocyte number |
decreased mature B cell number |
decreased B-2 B cell number |
decreased follicular B cell number |
decreased marginal zone B cell number |
decreased B cell number |
increased pre-B cell number |
abnormal T cell number |
decreased CD4-positive, alpha-beta memory T cell number |
decreased CD4-positive, alpha-beta T cell number |
decreased CD8-positive, alpha-beta T cell number |
increased memory T cell number |
decreased regulatory T cell number |
increased activated T cell number |
increased single-positive T cell number |
increased macrophage cell number |
increased monocyte cell number |
increased leukocyte cell number |
abnormal marginal zone B cell morphology |
small spleen |
spleen atrophy |
absent spleen germinal center |
decreased IgA level |
increased IgA level |
increased IgE level |
decreased IgG1 level |
decreased IgG2b level |
increased IgG level |
abnormal T cell activation |
abnormal macrophage physiology |
abnormal circulating cytokine level |
increased circulating interleukin-1 alpha level |
increased circulating interleukin-17 level |
increased circulating tumor necrosis factor level |
abnormal tumor necrosis factor level |
decreased Peyer's patch number |
small Peyer's patches |
abnormal humoral immune response |
autoimmune response |
increased anti-insulin autoantibody level |
increased anti-nuclear antigen antibody level |
chronic inflammation |
dermatitis |
increased susceptibility to bacterial infection induced morbidity/mortality |
|
Availability | Mouse Genotype | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nfkbiatm1.1Kbp/Nfkbiatm1.1Kbp | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nfkbiatm1.1Pjc/Nfkbiatm1.1Pjc | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nfkbiatm1.1Smiy/Nfkbiatm1.1Smiy | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nfkbiatm1Bal/Nfkbiatm1Bal | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nfkbiatm1Fey/Nfkbiatm1Fey | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nfkbiatm1Stw/Nfkbiatm1Stw | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nfkbiatm1.1Smiy/Nfkbia+ |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/30/2024 MGI 6.23 |
|
|